McKesson outlines fiscal 2027 adjusted EPS of $45.60-$46.40 and closes $2.25 billion deal
Seeking Alpha · · AI-summarised by FinFlash
McKesson outlined fiscal 2027 adjusted earnings per share of $45.60 to $46.40 while closing its $2.25 billion Precision Medicine Group deal, according to a Seeking Alpha market news item on the drug distributor's outlook. The shares were shown up 6.98% on the feed. The outlook adds to a strong week for healthcare stocks following the Democratic sweep of the US midterm elections.
So What?
The guide and deal add to the bullish case for drug distributors. Watch how quickly the Precision Medicine business contributes to earnings.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.